A048530 Share Price Performance
₩3,760.00
-2420.00 (-39.16%)
Price ₩3,760.00
Share Price₩3,760.00
iNtRON Biotechnology (KOSDAQ:048530) Is In A Strong Position To Grow Its Business
Nov 15
iNtRON Biotechnology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A048530 Community Narratives
There are no narratives available yet.
iNtRON Biotechnology, Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -187.90
- Gross Margin
- 51.96%
- Net Profit Margin
- -115.52%
- Debt/Equity Ratio
- 6.2%
iNtRON Biotechnology, Inc. Competitors
Snowflake Analysis
About A048530
- Founded
- 1999
- Employees
- 71
- CEO
- WebsiteView website
iNtRON Biotechnology, Inc. engages in the development of novel drugs in South Korea. It develops bacteriophage and endolysin based drugs. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
South Korean Market Performance
- 7 Days: 3.4%
- 3 Months: 13.2%
- 1 Year: 33.0%
- Year to Date: 44.6%
Over the last 7 days, the market has risen 3.4%, driven by gains of 7.2% in the Information Technology sector. As for the past 12 months, the market is up 33%. Earnings are forecast to grow by 24% annually. Market details ›